“ The primary focus of our research group is to develop noninvasive and minimally invasive drug delivery systems and technologies to deliver drugs across the biological barriers. Current research projects are aimed at developing patient compliant therapies for the treatment of chronic disorders such as cancer, neurological disorders, skin and nail diseases. We are also interested in investigating the plasma pharmacokinetics, dermatokinetics and brain distribution of novel therapeutic molecules.”